• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.

作者信息

Kempf Marie, Djouhri-Bouktab Lamia, Brunel Jean-Michel, Raoult Didier, Rolain Jean-Marc

出版信息

Int J Antimicrob Agents. 2012 Feb;39(2):180-1. doi: 10.1016/j.ijantimicag.2011.10.001. Epub 2011 Nov 17.

DOI:10.1016/j.ijantimicag.2011.10.001
PMID:22100281
Abstract
摘要

相似文献

1
Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.舒巴坦与黏菌素联合对耐黏菌素鲍曼不动杆菌的协同活性。
Int J Antimicrob Agents. 2012 Feb;39(2):180-1. doi: 10.1016/j.ijantimicag.2011.10.001. Epub 2011 Nov 17.
2
In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.替加环素单独及与硫酸黏菌素或舒巴坦联合应用对从重症监护病房分离出的对碳青霉烯类敏感及耐药的鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2010 Aug;36(2):191-2. doi: 10.1016/j.ijantimicag.2010.04.004. Epub 2010 May 26.
3
Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007.1997-2007 年间台湾一家医学中心三种表型未分化鲍曼不动杆菌复合群中对亚胺培南、美罗培南、舒巴坦和多黏菌素耐药趋势的差异。
J Microbiol Immunol Infect. 2011 Oct;44(5):358-63. doi: 10.1016/j.jmii.2011.01.032. Epub 2011 Jan 20.
4
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.碳青霉烯/舒巴坦合剂、多黏菌素、多黏菌素/利福平合剂及替加环素对耐碳青霉烯鲍曼不动杆菌的体外活性
J Antimicrob Chemother. 2007 Aug;60(2):317-22. doi: 10.1093/jac/dkm136. Epub 2007 May 31.
5
In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.黏菌素和氨苄西林/舒巴坦对鲍曼不动杆菌的体外活性。
J Med Assoc Thai. 2011 Aug;94 Suppl 3:S95-100.
6
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.黏菌素与替加环素或β-内酰胺类抗生素/β-内酰胺酶抑制剂组合对耐碳青霉烯类鲍曼不动杆菌的体外协同活性。
J Int Med Res. 2013 Dec;41(6):1830-7. doi: 10.1177/0300060513496172.
7
Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.醋酸钙不动杆菌-鲍曼不动杆菌复合体对亚胺培南、美罗培南、舒巴坦和黏菌素的敏感性。
Int J Antimicrob Agents. 2004 May;23(5):487-93. doi: 10.1016/j.ijantimicag.2003.09.026.
8
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.黏菌素、利福平、亚胺培南和舒巴坦/氨苄西林单独或联合使用对产OXA-58碳青霉烯酶的流行多重耐药鲍曼不动杆菌分离株的比较活性。
Int J Antimicrob Agents. 2007 Dec;30(6):537-40. doi: 10.1016/j.ijantimicag.2007.07.007. Epub 2007 Sep 11.
9
Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.替加环素、硫酸粘菌素和左氧氟沙星单独及替加环素-硫酸粘菌素和替加环素-左氧氟沙星联合应用对鲍曼不动杆菌的抗生素后效应。
Chemotherapy. 2010;56(6):466-71. doi: 10.1159/000321015. Epub 2010 Nov 18.
10
In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.采用棋盘法检测黏菌素联合舒巴坦对泛耐药鲍曼不动杆菌的体外活性。
J Med Assoc Thai. 2014 Mar;97 Suppl 3:S1-6.

引用本文的文献

1
The intricacies of : a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications.……的复杂性：对一种多重耐药病原体及其临床意义和影响的多方面综合综述。 （注：原文开头部分不完整，翻译出来的句子也有部分成分缺失，不太能构成完整通顺的表述）
Front Microbiol. 2025 May 12;16:1565965. doi: 10.3389/fmicb.2025.1565965. eCollection 2025.
2
Carbapenem-resistant and Ventilator-associated Pneumonia; Epidemiology, Risk Factors, and Current Therapeutic Approaches.耐碳青霉烯类与呼吸机相关性肺炎：流行病学、危险因素及当前治疗方法
J Res Pharm Pract. 2024 Dec 23;13(2):33-40. doi: 10.4103/jrpp.jrpp_50_24. eCollection 2024 Apr-Jun.
3
High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review.
大剂量雾化吸入多粘菌素甲磺酸钠及其在由具有难治性耐药性的革兰氏阴性菌引起的医院获得性肺炎中的作用：综述
Microorganisms. 2023 May 31;11(6):1459. doi: 10.3390/microorganisms11061459.
4
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.头孢地尔罗与多粘菌素联合方案治疗碳青霉烯类耐药鲍曼不动杆菌引起的严重感染的比较。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0214221. doi: 10.1128/aac.02142-21. Epub 2022 Mar 21.
5
Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists.鲍曼不动杆菌感染治疗的当代观点：来自传染病药师协会的见解
Infect Dis Ther. 2021 Dec;10(4):2177-2202. doi: 10.1007/s40121-021-00541-4. Epub 2021 Oct 14.
6
Comparison of Intravenous Ampicillin-sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Randomized Open Label Trial.静脉注射氨苄西林-舒巴坦联合雾化吸入多黏菌素与静脉注射多黏菌素联合雾化吸入多黏菌素治疗多重耐药菌所致呼吸机相关性肺炎的比较：随机开放标签试验
Iran J Pharm Res. 2019 Fall;18(Suppl1):269-281. doi: 10.22037/ijpr.2019.112466.13775.
7
Multidrug-resistant strains with NDM-1: Molecular characterization and efficacy of meropenem-based combinations.携带NDM-1的多重耐药菌株：基于美罗培南联合用药的分子特征及疗效
Exp Ther Med. 2019 Oct;18(4):2924-2932. doi: 10.3892/etm.2019.7927. Epub 2019 Aug 20.
8
Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant .比较代谢组学揭示了与多粘菌素和舒巴坦联合对多重耐药菌协同杀菌相关的关键途径。
Front Pharmacol. 2019 Jul 4;10:754. doi: 10.3389/fphar.2019.00754. eCollection 2019.
9
Colistin versus Colistin Combined with Ampicillin-Sulbactam for Multiresistant Ventilator-associated Pneumonia Treatment: An Open-label Prospective Study.多粘菌素与多粘菌素联合氨苄西林-舒巴坦治疗多重耐药呼吸机相关性肺炎的开放标签前瞻性研究
Indian J Crit Care Med. 2018 Feb;22(2):67-77. doi: 10.4103/ijccm.IJCCM_302_17.
10
New Shuttle Vectors for Gene Cloning and Expression in Multidrug-Resistant Acinetobacter Species.新型穿梭载体用于多药耐药不动杆菌属中的基因克隆和表达。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02480-17. Print 2018 Apr.